E-PaperDr Reddys Laboratories Q3 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01023
- Sector: Biotechnology & Drugs
BSE
6,840.1
22.95 (0.34%)
22.95 (0.34%)Volume2.98 K
Updated: Thu 25 Jul, 2024 | 13:57:08
NSE
6,835.915.75 (0.23%)
15.75 (0.23%)Volume1.77 L
Updated: Thu 25 Jul, 2024 | 13:43:30
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Dr Reddys Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 7,236.80 | 6,902.60 | 4.84% | 6,789.80 | 6.58% |
| Selling/ General/ Admin Expenses Total | 3,026.70 | 2,885.80 | 4.88% | 2,836.50 | 6.71% |
| Depreciation/ Amortization | 373.50 | 375.50 | -0.53% | 323.70 | 15.38% |
| Total Operating Expense | 5,587.20 | 5,171.40 | 8.04% | 5,175.00 | 7.97% |
| Operating Income | 1,649.60 | 1,731.20 | -4.71% | 1,614.80 | 2.16% |
| Net Income Before Taxes | 1,829.10 | 1,916.70 | -4.57% | 1,637.70 | 11.69% |
| Net Income | 1,380.90 | 1,482.20 | -6.83% | 1,243.90 | 11.01% |
| Diluted Normalized EPS | 83.31 | 84.60 | -1.53% | 75.37 | 10.53% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Buy or sell: Vaishali Parekh recommends three stocks to buy today — July 25
2 min read08:32 AM IST - Markets
02RNFI Services IPO booked over 221 times on the third bidding day, NIIs steal the show; check GMP
3 min read24 Jul 2024 - Markets
03Gold rate today: Yellow metal falls by over ₹1,100 to below ₹68,000; silver price drops over 4%. Should you buy?
3 min read10:39 AM IST